Cargando…
Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models
Interleukin (IL)-20 is a proinflammatory cytokine in the IL–10 family. IL–20 is associated with tumor promotion in the pathogenesis of oral, bladder, and breast cancer. However, little is known about the role of IL–20 in prostate cancer. We hypothesize that IL–20 promotes the growth of prostate canc...
Autores principales: | Hsu, Yu-Hsiang, Wu, Cheng-Ying, Hsing, Chung-Hsi, Lai, Wei-Ting, Wu, Li-Wha, Chang, Ming-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594924/ https://www.ncbi.nlm.nih.gov/pubmed/26440411 http://dx.doi.org/10.1371/journal.pone.0139871 |
Ejemplares similares
-
Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma
por: Chiu, Yi-Shu, et al.
Publicado: (2017) -
Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis
por: Hsu, Yu-Hsiang, et al.
Publicado: (2017) -
Anti-IL-20 monoclonal antibody promotes bone fracture healing through regulating IL-20-mediated osteoblastogenesis
por: Hsu, Yu-Hsiang, et al.
Publicado: (2016) -
Anti–IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss
por: Hsu, Yu-Hsiang, et al.
Publicado: (2011) -
Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013)